MUC5AC and carcinoma of the ampulla of vater: Another study on ampullary carcinoma, which set the cutoff for MUC5AC positivity at either >25% or 1%, reported significant survival differences between MUC5AC-positive and MUC5AC-negative patients, regardless of the histological subtype [16].